ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting

January 14, 1983

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

White House Budget asks $1.101 Billion For NCI In FY 1985; R01-P01 Pool Goes Up By 5.5 Percent

February 10, 1984